{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:43:10Z","timestamp":1793187790963,"version":"4.5.0"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Medical Society of Finland and Orion Research foundation"},{"name":"Iris foundation and Hjalmar Svensson Foundation"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Royal Australasian College of Physicians Foundation Roger Bartop Research Establishment Fellowship","id":[{"id":"https:\/\/ror.org\/03ve4rt72","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Available evidence has shown that metformin improves insulin sensitivity and weight management in polycystic ovary syndrome (PCOS). Nevertheless, key knowledge gaps remain regarding its efficacy and the specific outcomes in this population. This review evaluates the effectiveness of metformin and lifestyle modification compared with placebo in the management of PCOS and will inform the forthcoming, 2023 evidence-based PCOS guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis of the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A search was performed in MEDLINE, EMBASE, PsycINFO, All EBM, and CINAHL. The review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines and included randomized controlled trials published in English through July 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Moderate certainty of evidence showed a larger reduction of body mass index (BMI) (mean difference [MD] \u22120.53, 95% confidence interval [CI] \u22120.95 to \u22120.12\u2005kg\/m2), homeostatic model assessment for insulin resistance (MD \u22120.50, 95% CI \u22120.91 to \u22120.09) (critical outcomes), and fasting glucose (MD \u22120.13, 95% CI \u22120.19 to \u22120.07\u2005mmol\/L) with metformin compared to placebo with increased mild gastrointestinal adverse effects (odds ratio [OR] 7.67, 95% CI 2.74\u201321.46). Low certainty of evidence showed a larger reduction of waist\u2013hip ratio (MD \u22120.02, 95% CI \u22120.03 to \u22120.00), total cholesterol (MD \u22120.24, 95% CI \u22120.43 to \u22120.05\u2005mmol\/L), low-density lipoprotein (MD \u22120.16, 95% CI \u22120.30 to \u22120.01\u2005mmol\/L), and triglycerides (MD \u22120.11, 95% CI \u22120.20 to \u22120.02\u2005mmol\/L) with metformin than placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Metformin should be considered an efficacious adjunct to lifestyle interventions in adults with PCOS, especially for those with a higher BMI, to improve weight loss, insulin resistance, and lipids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvad098","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T18:17:17Z","timestamp":1691086637000},"page":"S38-S64","source":"Crossref","is-referenced-by-count":72,"title":["The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-7097","authenticated-orcid":false,"given":"Johanna","family":"Melin","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of public Health and Preventive Medicine, Monash University , Clayton, VIC 3168 , Australia"},{"name":"Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital , 00014 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-3849","authenticated-orcid":false,"given":"Maria","family":"Forslund","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of public Health and Preventive Medicine, Monash University , Clayton, VIC 3168 , Australia"},{"name":"Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , 40530 Gothenburg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9970-622X","authenticated-orcid":false,"given":"Simon","family":"Alesi","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of public Health and Preventive Medicine, Monash University , Clayton, VIC 3168 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-7300","authenticated-orcid":false,"given":"Terhi","family":"Piltonen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Research Unit of Clinical Medicine and Medical Research Centre, Oulu University Hospital, University of Oulu , 90014 Oulu , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5236-2586","authenticated-orcid":false,"given":"Daniela","family":"Romualdi","sequence":"additional","affiliation":[{"name":"Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS , 00168 Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poli Mara","family":"Spritzer","sequence":"additional","affiliation":[{"name":"Gynecological Endocrinology Unit, Division of Endocrinology, Hospital de Cl\u00ednicas de Porto Alegre, Universidade Federal do Rio Grande do Sul , Porto Alegre, RS 90035-003 , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau Thien","family":"Tay","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of public Health and Preventive Medicine, Monash University , Clayton, VIC 3168 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Pena","sequence":"additional","affiliation":[{"name":"Discipline of Paediatics, The University of Adelaide and Robinson Research Institute , Adelaide, South Australia 5005 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma Feldman","family":"Witchel","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh , Pittsburgh, PA 15224 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7356-4523","authenticated-orcid":false,"given":"Aya","family":"Mousa","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of public Health and Preventive Medicine, Monash University , Clayton, VIC 3168 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-577X","authenticated-orcid":false,"given":"Helena","family":"Teede","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of public Health and Preventive Medicine, Monash University , Clayton, VIC 3168 , Australia"},{"name":"Endocrine and Diabetes Units, Monash Health , Clayton, VIC 3169, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"issue":"12","key":"2023100618073723700_lvad098-B1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"issue":"9","key":"2023100618073723700_lvad098-B2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"issue":"1","key":"2023100618073723700_lvad098-B3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"issue":"7","key":"2023100618073723700_lvad098-B4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2015","journal-title":"Am J Hypertens"},{"issue":"9","key":"2023100618073723700_lvad098-B5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2023100618073723700_lvad098-B6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/aogs.14382","article-title":"Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: A population-based cohort study","volume":"101","author":"Kujanpaa","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"2023100618073723700_lvad098-B7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic\u2013hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"issue":"11","key":"2023100618073723700_lvad098-B8","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic\u2013hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"issue":"S6","key":"2023100618073723700_lvad098-B9","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"issue":"8","key":"2023100618073723700_lvad098-B10","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"Teede","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"2023100618073723700_lvad098-B11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/cen.14205","article-title":"Physical activity and sedentary behaviour in women with and without polycystic ovary syndrome: an Australian population-based cross-sectional study","volume":"93","author":"Tay","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2023100618073723700_lvad098-B12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/nu9090996","article-title":"Weight management interventions in women with and without PCOS: a systematic review","volume":"9","author":"Kataoka","year":"2017","journal-title":"Nutrients"},{"issue":"4","key":"2023100618073723700_lvad098-B13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cen.14013","article-title":"Effect of the combined oral contraceptive pill and\/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses","volume":"91","author":"Teede","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"jul21 1","key":"2023100618073723700_lvad098-B14","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2023100618073723700_lvad098-B15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2023100618073723700_lvad098-B16","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2023100618073723700_lvad098-B17","author":"GRADE working Group"},{"issue":"2","key":"2023100618073723700_lvad098-B18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12020-014-0403-y","article-title":"Metformin in women with PCOS, pros","volume":"48","author":"Pasquali","year":"2015","journal-title":"Endocrine"},{"issue":"2","key":"2023100618073723700_lvad098-B19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023100618073723700_lvad098-B20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.0.1470217","article-title":"The effect of metformin on hirsutism in polycystic ovary syndrome","volume":"147","author":"Kelly","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023100618073723700_lvad098-B21","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2005-1994","article-title":"Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial","volume":"91","author":"Eisenhardt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023100618073723700_lvad098-B22","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023100618073723700_lvad098-B23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome\u2014a randomised, double-blind, placebo-controlled trial","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"issue":"1","key":"2023100618073723700_lvad098-B24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"issue":"8","key":"2023100618073723700_lvad098-B25","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1210\/jc.2007-0441","article-title":"Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2023100618073723700_lvad098-B26","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/humrep\/dem271","article-title":"Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-overtrial","volume":"22","author":"Trolle","year":"2007","journal-title":"Hum Reprod"},{"issue":"7","key":"2023100618073723700_lvad098-B27","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.fertnstert.2009.01.114","article-title":"Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial","volume":"93","author":"Romualdi","year":"2010","journal-title":"Fertil Steril"},{"issue":"6","key":"2023100618073723700_lvad098-B28","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.fertnstert.2010.01.057","article-title":"Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study","volume":"94","author":"Trolle","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"2023100618073723700_lvad098-B29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.fertnstert.2010.06.058","article-title":"Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study","volume":"95","author":"Naka","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"2023100618073723700_lvad098-B30","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023100618073723700_lvad098-B31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fertnstert.2019.04.013","article-title":"Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study","volume":"112","author":"Lingaiah","year":"2019","journal-title":"Fertil Steril"},{"issue":"2","key":"2023100618073723700_lvad098-B32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"issue":"3","key":"2023100618073723700_lvad098-B33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"2023100618073723700_lvad098-B34","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023100618073723700_lvad098-B35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2010.12.002","article-title":"The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertil Steril"},{"issue":"8","key":"2023100618073723700_lvad098-B36","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.fertnstert.2011.05.048","article-title":"Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertil Steril"},{"issue":"12","key":"2023100618073723700_lvad098-B37","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.mayocp.2019.06.015","article-title":"Effect of metformin on microvascular endothelial function in polycystic ovary syndrome","volume":"94","author":"Heidari","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2023100618073723700_lvad098-B38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2003-39056","article-title":"Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double blind and placebo-controlled trial","volume":"35","author":"Chou","year":"2003","journal-title":"Horm Metab Res"},{"issue":"4","key":"2023100618073723700_lvad098-B39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"2023100618073723700_lvad098-B40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","article-title":"Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin","volume":"81","author":"Maciel","year":"2004","journal-title":"Fertil Steril"},{"issue":"3","key":"2023100618073723700_lvad098-B41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/09513590903215581","article-title":"Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial","volume":"26","author":"Fux Otta","year":"2010","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"2023100618073723700_lvad098-B42","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/humrep\/16.8.1625","article-title":"Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial","volume":"16","author":"Ng","year":"2001","journal-title":"Hum Reprod"},{"issue":"2","key":"2023100618073723700_lvad098-B43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2005.05.010","article-title":"Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?","volume":"123","author":"Onalan","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2023100618073723700_lvad098-B44","first-page":"174","article-title":"The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome","volume":"12","author":"Karimzadeh","year":"2007","journal-title":"Middle East Fertil Soc J"},{"issue":"4","key":"2023100618073723700_lvad098-B45","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1447-0756.2012.02051.x","article-title":"Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome","volume":"39","author":"Esfahanian","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"2023100618073723700_lvad098-B46","first-page":"205","article-title":"Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese\/overweight PCOS women under hypocaloric diet","volume":"15","author":"Amiri","year":"2014","journal-title":"J Reprod Infertil"},{"issue":"2","key":"2023100618073723700_lvad098-B47","first-page":"103","article-title":"Effects of metformin on endocrine and metabolic parameters in patients with polycystic ovary syndrome","volume":"49","author":"Zahra","year":"2017","journal-title":"Horm Metab Res"},{"issue":"3","key":"2023100618073723700_lvad098-B48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tjog.2018.04.015","article-title":"The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystic ovary syndrome: a randomized controlled study","volume":"57","author":"Bodur","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2023100618073723700_lvad098-B49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejogrb.2018.12.021","article-title":"Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome","volume":"234","author":"Tiwari","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"2023100618073723700_lvad098-B50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MED.0000000000000095","article-title":"Effects of metformin on weight loss: potential mechanisms","volume":"21","author":"Malin","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"2023100618073723700_lvad098-B51","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023100618073723700_lvad098-B52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"issue":"1","key":"2023100618073723700_lvad098-B53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/humrep\/deab239","article-title":"Weight gain and lifestyle factors in women with and without polycystic ovary syndrome","volume":"37","author":"Awoke","year":"2022","journal-title":"Hum Reprod"},{"issue":"9","key":"2023100618073723700_lvad098-B54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"2","key":"2023100618073723700_lvad098-B55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/humrep\/dew329","article-title":"Overweight and obese but not normal weight women with PCOS are at increased risk of type 2 diabetes mellitus\u2014a prospective, population-based cohort study","volume":"32","author":"Ollila","year":"2017","journal-title":"Hum Reprod"},{"issue":"1","key":"2023100618073723700_lvad098-B56","doi-asserted-by":"crossref","first-page":"hoz042","DOI":"10.1093\/hropen\/hoz042","article-title":"Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution","volume":"2020","author":"Forslund","year":"2020","journal-title":"Hum Reprod Open"},{"issue":"6","key":"2023100618073723700_lvad098-B57","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023100618073723700_lvad098-B58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0015-0282(16)60060-2","article-title":"The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism","volume":"50","author":"Barbieri","year":"1988","journal-title":"Fertil Steril"},{"issue":"1","key":"2023100618073723700_lvad098-B59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","article-title":"Sex hormone binding globulin\u2014an important biomarker for predicting PCOS risk: A systematic review and meta-analysis","volume":"1","author":"Deswal","year":"2018","journal-title":"Syst Biol Reprod Med"},{"issue":"12","key":"2023100618073723700_lvad098-B60","first-page":"e306","article-title":"Metformin therapy for the management of infertility in women with polycystic ovary syndrome: scientific impact paper No. 13","volume":"124","author":"Morley","year":"2017","journal-title":"BJOG"},{"key":"2023100618073723700_lvad098-B61","first-page":"Cd003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"5","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2023100618073723700_lvad098-B62","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/jc.2015-3543","article-title":"Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study","volume":"101","author":"Ollila","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023100618073723700_lvad098-B63","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2023100618073723700_lvad098-B64","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"2023100618073723700_lvad098-B65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dms036","article-title":"Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"19","author":"Misso","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"12","key":"2023100618073723700_lvad098-B66","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1210\/jc.2013-2374","article-title":"Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"98","author":"Domecq","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvad098\/51035152\/lvad098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/2\/S38\/51916525\/lvad098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/2\/S38\/51916525\/lvad098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T14:08:31Z","timestamp":1696601311000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/189\/2\/S38\/7236786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvad098","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,8]]}}}